Inventor · Snohomish, WA, US

Ethan W. Ojala

65Patents
11h-index
37Co-inventors
74Inventor score

Filing activity: May 21, 2008 → Jun 27, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7935340B2 Antibodies to IL-6 and use thereof Chemistry; Metallurgy 82 Active
US8323649B2 Antibodies to IL-6 and use thereof Emerging Cross-Sectional Technologies 54 Active
US8062864B2 Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies Chemistry; Metallurgy 50 Active
US8178101B2 Use of anti-IL-6 antibodies having specific binding properties to treat cachexia Chemistry; Metallurgy 48 Active
US8911734B2 Methods of preventing or treating pain using anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75 Emerging Cross-Sectional Technologies 38 Active
US9255154B2 Anti-PCSK9 antibodies and use thereof Physics 32 Active
US8728473B2 Methods of preventing or treating pain using anti-NGF antibodies Emerging Cross-Sectional Technologies 26 Active
US9085615B2 Antibodies to IL-6 to inhibit or treat inflammation Emerging Cross-Sectional Technologies 24 Active
US9884912B2 Antibodies to IL-6 and use thereof Chemistry; Metallurgy 15 Active
US9518082B2 Antibody purification and purity monitoring Chemistry; Metallurgy 13 Active
US9056905B2 Antibodies to TNF-α and use thereof Chemistry; Metallurgy 11 Active
US10533045B2 Antibody purification and purity monitoring Chemistry; Metallurgy 9 Active
US9725509B2 Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody Chemistry; Metallurgy 8 Active
US9758579B2 Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity Chemistry; Metallurgy 8 Active
US10202435B2 Anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 6 Active
US9834603B2 Antibodies to IL-6 and use thereof Chemistry; Metallurgy 2 Active
US9783602B2 Anti-NGF compositions and use thereof Emerging Cross-Sectional Technologies 2 Active
US9879074B2 Antibodies to IL-6 and use thereof Emerging Cross-Sectional Technologies 2 Active
US10047157B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10550180B2 Anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10913783B2 Humanized anti-PACAP antibodies and uses thereof Emerging Cross-Sectional Technologies 1 Active
US9771421B2 Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies Chemistry; Metallurgy 1 Active
US11117960B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US11427631B2 Anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active
US10544214B2 Humanized anti-ACTH antibodies and use thereof Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.